Drug users' participation in a free hepatitis B vaccination program: Demographic, behavioral, and social-cognitive determinants

Substance Use and Misuse

Volumn 43, Issue 14, 2008, Pages 2145-2162

  Baars, Jessica ^a,b   Boon, Brigitte ^a   De Wit, John B ^c,g   Schutten, Merel ^d   Van Steenbergen, Jim E ^e   Garretsen, Henk F ^a,f   Van De Mheen, Dike ^a,b  

^a Addiction Research Institute Rotterdam   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

^d Munic Hlth Serv Zuid Holland Zuid   (Netherlands)

^e NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^f TILBURG UNIVERSITY   (Netherlands)

^g UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Drug users; Health behavior; Hepatitis B; Prevention; Social cognitive determinants; Vaccination

Indexed keywords

HEPATITIS B VACCINE;

ADULT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DEMOGRAPHY; DRUG ABUSE; FEMALE; HEPATITIS B; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; VACCINATION;

ADULT; CONSUMER PARTICIPATION; FEMALE; HEALTH BEHAVIOR; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION PROGRAMS; MALE; MIDDLE AGED; NETHERLANDS; PILOT PROJECTS; PROGRAM EVALUATION; PROSPECTIVE STUDIES; QUESTIONNAIRES; SUBSTANCE-RELATED DISORDERS;

EID: 57649123158     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.1080/10826080802344609     Document Type: Article

References (38)

1. Abraham, C., Sheeran, P., Norman, N., Conner, P., de Vries, N., Otten, W. (1999). When good intentions are not enough: modeling post-intention cognitive correlates of condom use. Journal of Applied Social Psychology 29:2591-2612.
2. Ajzen, I. (1991). The theory of planned behavior. Organizational Behavior and Human Decision Processes 50:179-211.
3. Altice, F. L., Bruce, R. D., Walton, M. R., Buitrago, M. I. (2005). Adherence to hepatitis B virus vaccination at syringe exchange sites. Journal of Urban Health 82(1):151-161. E pub March 3.
4. Bock, H. L. (2003). Rapid hepatitis B immunization for the traveler: comparison of two accelerated schedules with a 2-month schedule. BioDrugs 17(Suppl 1):11-13.
5. Booth, R. E., Kwiatkowski, C. F., Chitwood, D. D. (2000). Sex related HIV risk behaviors: differential risks among injection drug users, crack smokers, and injection drug users who smoke crack. Drug and Alcohol Dependence 58:219-226.
6. Budd, J., Robertson, R., Elton, R. (2004). Hepatitis B vaccination and injecting drug users. British Journal of General Practice 54:444-447.
7. Centers for Diseases Control and Prevention (1982). Inactivated hepatitis B vaccine. Morbidity and Mortality Weekly Report 31:317-318.
8. Christensen, P. B., Fisker, N., Krarup, H. B., Liebert, E., Jaroslavtsev, N., Christensen, K., Gorgsen, J. (2004). Hepatitis B vaccination in prison with a 3-week schedule is more efficient than the standard 6-month schedule. Vaccine 44:3897-3901.
9. Choi, K. H., Operario, D., Gregorich, S. E., McFarland, W., MacKellar, D., Valleroy, L. (2005). Substance use, substance choice, and unprotected anal intercourse among young Asian American and Pacific Islander men who have sex with men. AIDS Education and Prevention 17(5):418-429.
10. Connor, M., Sparks, P. (1996). The theory of planned behavior. In M. Conner & P. Norman (Eds.), Predicting health behavior (pp. 121-162). Buckingham, UK: Open University Press.
11. De Boer, I. M., Op de Coul, E. L. M., Beuker, R. J., De Zwart, O., Al Taqatqa, W., Van de Laar, M. J. W. (2004). Trends in HIV prevalence and risk behaviour among injecting drug users in Rotterdam, 1994-2002. Nederlands Tijdschrift voor Geneeskunde 148(47):2325-2330.
12. De Wit, J. B., Vet, R., Schutten, M., Van Steenbergen, J. (2005). Social-cognitive determinants of vaccination behavior against hepatitis B: an assessment among men who have sex with men. Preventive Medicine 40(6):795-802.
13. Des Jarlais, D. C., Fisher, D. G., Newman, J. C., Trubatch, B. N., Yancovitz, M., Paone, D., Perlman, D. (2001). Providing hepatitis B vaccination to injection drug users: referral to health clinics vs on-site vaccination at a syringe exchange program. American Journal of Public Health 91(11):1791-1792.
14. EMCDDA (2001). Workgroup review of qualitative research on the health risk associated with injecting drug use. Lisbon, Portugal: European Monitoring Centre for Drugs and Drug Addiction. Accessed March 11, 2004 from http://qed.emcdda.eu.int.
15. EMCDDA (2003). The state of the drugs problem in the European Union and Norway. Lisbon, Portugal: European Monitoring Centre for Drugs and Drug Addiction. Retrieved January 19, 2006, from http://www.emcdda.eu.int.
16. Gollwitzer, P. M. (1999). Implementation intentions. Strong effects of simple plans. American Psychologist 54:493-503.
17. Kleinig, J., Einstein, S. (Eds.). (2006). Ethical challenges for intervening in drug use: policy, research and treatment issues. Huntsville, TX: OICJ.
18. Koester, S., Booth, R., Zhang, E. (1996). The prevalence of additional injection-related HIV risk behaviors among injection drug users. Journal of Acquired Immunodeficiency Syndrome and Human Retrovirology 12:202-207.
19. Lugoboni, F., Migliozzi, S., Mezzelani, P., Pajusco, B., Ceravolo, R., Quaglio, G. (2004). Progressive decrease of hepatitis B in a cohort of drug users followed over a period of 15 years: the impact of anti-HBV vaccination. Scandinavian Journal of Infectious Diseases 36(2):131-133.
20. Lum, P. J., Ochoa, K. C., Hahn, J. A., Page Shafer, K., Evans, J. L., Moss, A. R. (2003). Hepatitis B virus immunization among young injection drug users in San Francisco, Calif: the UFO Study. American Journal of Public Health 93(6):919-923.
21. McGregor, J., Marks, P. J., Hayward, A., Bell, Y., Slack, R. C. B. (2003). Factors influencing hepatitis B vaccine uptake in injecting drug users. Journal of Public Health 25(2):165-170.
22. Nothdurft, H. D., Dietrich, M., Zuckerman, J. N., Knobloch, J., Kern, P., Vollinar, J., Sänger, R. (2002). A new accelerated vaccination schedule for rapid protection against hepatitis A and B. Vaccine 20(7-8):1157-1162.
23. Ompad, D. C., Galea, S., Wu, Y., Fuller, C. M., Latka, M., Koblin, B., Vlahov, D. (2004) Acceptance and completion of hepatitis B vaccination among drug users in New York City. Communicable Disease and Public Health 7(4):294-300.
24. Orbell, S., Sheeran, P. (1998). 'Inclined abstainers': a problem for predicting health-related behaviour. British Journal of Social Psychology 37:151-165.
25. Quaglio, G. L., Tamini, G., Lugoboni, F., Lechi, A., Venturini, L., Des Jarlais, D. C., Mezzelani, P. (2002). Compliance with hepatitis B vaccination in 1175 heroin users and risk factors associated with lack of vaccine response. Addiction 97:985-992.
26. Rhodes, S. D., Grimley, D. M. Hergenrather, K. C. (2003). Integrating behavioral theory to understand hepatitis B vaccination among men who have sex with men. American Journal of Health Behavior 27(4):291-300.
27. Rogers, N., Lubman, D. I. (2005). An accelerated hepatitis B vaccination schedule for young drug users. Australian and New Zealand Journal of Public Health 29:305-307.
28. Rosenstock, I. M. (1965). Why people use health services. Milbank Quarterly 44:94-127.
29. Rosenstock, I. M. (1974). Historical origins of the health belief model. Health Education Monographs 2:1-8.
30. Seal, K. H., Kral, A. H., Lorvick, J., McNees, A., Gee, L., Edlin, B. R. (2003). A randomized controlled trial of monetary incentives vs. outreach to enhance adherence to the hepatitis B vaccine series among injection drug users. Drug and Alcohol Dependence 71(2):127-131.
31. Sheeran, P., Abraham, C. (1996). The health belief model. In M. Conner & P. Norman (Eds.), Predicting health behavior (pp. 23-61). Buckingham, UK: Open University Press.
32. Sheeran, P. (2002). Intention-behavior relations: a conceptual and empirical review. In W. Stroebe & M. Hewstone (Eds.), European Review of Social Psychology 12: (1-36).
33. Sheeran, P., Abraham, C. (2003). Mediator of moderators: temporal stability of intention and the intention-behavior relation. Personality and Social Psychology Bulletin 12:1-30. Chichester, UK: Wiley.
34. Van Houdt, R., Sonder, G. J. B., Dukers, N. H. T. M., Bovee, L. P. M. J., Van den Hoek, A., Coutinho, R. A., Bruisten, S. M. (2006). Impact of a targeted hepatitis B vaccination program in Amsterdam, The Netherlands. Vaccine 25(14):2698-2705.
35. Van Steenbergen, J. E. (2002). Results of an enhanced-outreach programme of hepatitis B vaccination in the Netherlands (1998-2000) among men who have sex with men, hard drug users, sex workers and heterosexual persons with multiple partners. Journal of Hepatology 37(4):507-513.
36. Watters, J. K., Biernacki, P. (1989). Targeted sampling: Options for the study of hidden populations. Social Problems 36:416-430.
37. WHO (2000). Hepatitis B fact sheet No204. Geneva: World Health Organization. Retrieved February 15, 2006, from http://www.who.int.
38. Wright, N. M. J., Campbell, T. L., Tompkins, C. N. E. (2002). Comparison of conventional and accelerated hepatitis B schedules for homeless drug users. Communicable diseases and public health 5(4):324-326.